Sponsor Pipeline

Cellbion Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
0
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 1/2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT05547061 A Phase 1/2 Clinical Trial to Evaluate the Safety, Tolerability, Dosimetry, and… Prostate Cancer Active, Not Recruiting
Phase 1
NCT07244393 Lutetium (177Lu) DGUL Combined With Pembrolizumab in Metastatic Castration-Resistant… Metastatic Castration-resistant Prostate Cancer (mCRPC) Not Yet Recruiting
Disease Areas
Prostate Cancer (2)
Get alerts when Cellbion Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free